1887

Abstract

The histopathology of adenovirus pneumonia in cotton rats () due to bovine adenovirus type 3-luciferase recombinant virus (BAd3-Luc), which has a 0.7 kb deletion from the early region 3 (E3) replaced with the firefly luciferase gene, was compared with that produced by the parental wild-type (wt) bovine adenovirus type 3 (BAd3). After intranasal inoculation of cotton rats with 3 × 10 p.f.u. of BAd3-Luc, the infectious virus titres in the lungs at various times post-infection were similar to those of animals infected with the parental virus. Quantitative analysis of histopathological changes and immunohistochemical staining showed that the character and severity of the lesions were indistinguishable in the two infections. Luciferase activity was detected in the lungs of BAd3-Lucinoculated animals until 4 days post-infection (p.i.). Antibodies to both BAd3 and luciferase were detected in sera collected from BAd3-Luc-infected animals until at least 6 weeks p.i. These results show that BAd3-Luc produces pulmonary lesions in cotton rats similar to those of wt BAd3 and suggest that BAd3-based vectors may be suitable for the development of live recombinant virus vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-1-1
1996-01-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/1/JV0770010001.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-1-1&mimeType=html&fmt=ahah

References

  1. Berkner K. L., Sharp P. A. 1984; Expression of dihydrofolate reductase and of the adjacent Elb region in an Ad5-dihydrofolate reductase recombinant virus. Nucleic Acids Research 12:1925–1941
    [Google Scholar]
  2. Bett A. J., Prevec L., Graham F. L. 1993; Packaging capacity and stability of human adenovirus type 5 vectors. Journal of Virology 67:5911–5921
    [Google Scholar]
  3. Braciak T. A., Mittal S. K., Graham F. L., Richards C. D., Gauldie J. 1993; Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes: an approach to investigate in vivo cytokine function. Journal of Immunology 151:5145–5153
    [Google Scholar]
  4. Breker-Klassen M. M., Yoo D., Mittal S. K., Sorden S. D., Haines D. M., Babiuk L. A. 1995; Recombinant adenovirus type 5 expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection. Journal of Virology 69:4308–4315
    [Google Scholar]
  5. Burgert H. G., Kvist S. 1987; The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO Journal 6:2019–2026
    [Google Scholar]
  6. Carlin C. R., Tollefson A. E., Bradley H. A., Hoffman B. L., Wold W. S. M. 1989; Epidermal growth factor is downregulated by a 10, 400 MW protein encoded by the E3 region of adenovirus. Cell 57:135–144
    [Google Scholar]
  7. Chanda P. K., Natuk R. J., Mason B. B., Bhat B. M., Greenberg L., Dheer S. K., Molnar-Kimber K. L., Mizutani S., Lubeck M. D., Davis A. R., Hung P. P. 1990; High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in the presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175:535–547
    [Google Scholar]
  8. Cladaras C., Wold W. S. M. 1985; The sequence of the early E3 transcription unit of adenovirus 5. Virology 140:28–43
    [Google Scholar]
  9. Darbyshire J. H. 1968; Bovine adenoviruses. Journal of American Veterinary Medical Association 152:786–794
    [Google Scholar]
  10. Darbyshire J. H., Jennings A. R., Omar A. R., Dawson P. S., Lamont P. H. 1965; Association of adenoviruses with bovine respiratory disease. Nature 208:307–308
    [Google Scholar]
  11. Darbyshire J. H., Jennings A. R., Dawson P. S., Lamont P. H., Omar A. R. 1966; The pathogenesis and pathology of infection in calves with a strain of bovine adenovirus type 3. Research in Veterinary Science 7:81–93
    [Google Scholar]
  12. Engelhardt J. F., Ye X., Doranz B., Wilson J. M. 1994; Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proceedings of the National Academy of Sciences, USA 91:6196–6200
    [Google Scholar]
  13. Ghosh-Choudhury G., Haj-Ahmad Y., Graham F. L. 1987; Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO Journal 6:1733–1739
    [Google Scholar]
  14. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S. M., Chanock R. M., Prince G. A. 1989; Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of Sciences, USA 86:3823–3827
    [Google Scholar]
  15. Gooding L. R., Elmore L. W., Tollefson A. E., Brody H. A., Wold W. S. M. 1988; A 14, 700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341–346
    [Google Scholar]
  16. Graham F. L. 1990; Adenoviruses as expression vectors and recombinant vaccines. Trends in Biotechnology 8:85–87
    [Google Scholar]
  17. Graham F. L., Prevec L. 1991; Manipulation of adenovirus vectors. Methods in Molecular Biology 7:109–128
    [Google Scholar]
  18. Graham F. L., Prevec L. 1992; Adenovirus expression vectors and recombinant vaccines. In Vaccines: New Approaches to Immunological Problems pp. 363–390 Edited by Ellis R. W. Boston: Butterworth-Heinemann;
    [Google Scholar]
  19. Haines D. M., Chelack B. J. 1991; Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. Journal of Veterinary Diagnostics and Investigation 3:101–112
    [Google Scholar]
  20. Haj-Ahmad Y., Graham F. L. 1986; Development of a helper independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. Journal of Virology 57:267–274
    [Google Scholar]
  21. Ide P. R., Thompson R. G., Ditchfield W. J. B. 1969; Experimental adenovirus infection in calves. Canadian Journal of Comparative Medicine 33:1–9
    [Google Scholar]
  22. Mattson D. E. 1973a; Naturally occurring infection of calves with a bovine adenovirus. American Journal of Veterinary Research 34:623–629
    [Google Scholar]
  23. Mattson D. E. 1973b; Adenovirus infection in cattle. Journal of American Veterinary Medical Association 163:894–896
    [Google Scholar]
  24. Mattson D. E., Norman B. B., Dunbar J. R. 1988; Bovine adenovirus type 3 infection in feedlot calves. American Journal of Veterinary Research 49:67–69
    [Google Scholar]
  25. Mittal S. K., Prevec L., Babiuk L. A., Graham F. L. 1992; Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes. Journal of General Virology 73:3295–3300
    [Google Scholar]
  26. Mittal S. K., Prevec L., Babiuk L. A., Graham F. L. 1993a; Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes (corrigendum). Journal of General Virology 74:28–25
    [Google Scholar]
  27. Mittal S. K., McDermott M. R., Johnson D. C., Prevec L., Graham F. L. 1993b; Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28:67–90
    [Google Scholar]
  28. Mittal S. K., McDermott M. R., Johnson D. C., Prevec L., Zamb T., Babiuk L. A., Graham F. L. 1994; Adenovirus based expression vectors for recombinant vaccines. In Recombinant and Synthetic Vaccines pp. 362–366 Edited by Talwar G. P., Rao K. V. S., Chauhan V. S. New Delhi: Narosa Publishing House;
    [Google Scholar]
  29. Mittal S. K., Prevec L., Graham F. L., Babiuk L. A. 1995a; Development of a bovine adenovirus type 3-based expression vector. Journal of General Virology 76:93–102
    [Google Scholar]
  30. Mittal S. K., Bett A. J., Prevec L., Graham F. L. 1995b; Foreign gene expression by human adenovirus type 5 based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters. Virology 210:226–230
    [Google Scholar]
  31. Mittal S. K., Middleton D. M., Tikoo S. K., Babiuk L. A. 1995c; Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology 213:131–139
    [Google Scholar]
  32. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  33. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J. C., Perricaudet M., Kahn A. 1993; Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647–650
    [Google Scholar]
  34. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L., Perricaudet M., Guggino W. B., Pavirani A., Lecocq J.-P., Crystal R. G. 1992; In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:141–155
    [Google Scholar]
  35. Stott E. J., Thomas L. H., Collins A. P., Crouch S., Jebbett J., Smith G. S., Luther P. D., Caswell R. 1980; A survey of virus infections of the respiratory tract of cattle and their association with disease. Journal of Hygiene 85:257–270
    [Google Scholar]
  36. Tollefson A. E., Stewart A. R., Yei S., Saha S. K., Wold W. S. M. 1991; The 10, 400- and 14, 500-Dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. Journal of Virology 65:3095–3105
    [Google Scholar]
  37. Tufariello J., Cho S., Horwitz M. S. 1994; The adenovirus E3 14.7-kiloDalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. Journal of Virology 68:453–462
    [Google Scholar]
  38. Wold W. S. M., Hermiston T. W., Tollefson A. E. 1994; Adenovirus proteins that subvert host defenses. Trends in Microbiology 2:437–443
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-1-1
Loading
/content/journal/jgv/10.1099/0022-1317-77-1-1
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error